StreetAlpha.app
Home › Stocks › XRN

Chiron Real Estate Inc. (XRN)

$25.47
▼ −0.89%
LAST CLOSE · NOV 20

Chiron Real Estate is a real estate investment trust that owns healthcare properties leased to physician groups and healthcare systems. It last closed at $25.47 on Nov 20, down 0.89% on the day. The next earnings report for XRN is expected around Wed, Feb 24, 2027, after the close. For the quarter ended Sep 2026, XRN reported EPS of -$0.67 on revenue of $40.3M, with revenue up 8.3% from a year ago. Over its last 5 reports the stock moved an average of 4.7% the session after earnings. Over the last 12 months XRN insiders bought $3.5M of stock on the open market and sold $0, according to SEC Form 4 filings.

AI Auto Pilots
Is XRN in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold XRN.

Key Stats

Last 12 months
Results
Revenue
$156.5M
+8.0% vs a year ago
Net income
$62.1M
+2716.7% vs a year ago
EPS (diluted)
$3.50
Valuation
Market cap
$337.4M
13.2M shares
P/E
7.3
Price over 12 month EPS
Price to sales
2.2
Market cap over revenue
Dividend yield
5.18%
$1.32 a share over 12 months
Balance sheet
Cash & equivalents
$13.5M
At Sep 30
Shareholder equity
$652.6M
Shares outstanding
13.2M
At Nov 2
Fiscal year endsDecember
ExchangeNYSE
Financials history
FY2021: $115.9M$115.9MFY2021FY2022: $137.3M$137.3MFY2022FY2023: $141.0M$141.0MFY2023FY2024: $138.8M$138.8MFY2024FY2025: $148.2M$148.2MFY2025

From XRN's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Nov 6). Last 12 months adds up the four latest quarters.

Next report
Feb 24
Estimated date · After the close
Reported EPS
-$0.67
Quarter ended Sep 2026
Year ago EPS
-$0.45
Same quarter last year
Revenue
$40.3M
+8.3% vs a year ago
Estimates and implied move
Consensus forecasts and the move options price in
EPS by quarter (GAAP)
Dec 2024: $0.10Dec '24Mar 2025: $0.16Mar '25Jun 2025: -$0.06Jun '25Sep 2025: -$0.45Sep '25Dec 2025: -$0.56Dec '25Mar 2026: -$0.06Mar '26Jun 2026: $4.78Jun '26Sep 2026: -$0.67Sep '26Latest -$0.67
Revenue by quarter
Dec 2024: $35.2MDec '24Mar 2025: $34.6MMar '25Jun 2025: $38.0MJun '25Sep 2025: $37.2MSep '25Dec 2025: $38.4MDec '25Mar 2026: $38.1MMar '26Jun 2026: $39.7MJun '26Sep 2026: $40.3MSep '26Latest $40.3M
How XRN moved after its last 5 reports
Average move the session after a report ±4.7%
Nov 4, 2026After the close−6.1%
Aug 5, 2026After the close+1.1%
May 6, 2026After the close−9.2%
Feb 25, 2026After the close−1.6%
Nov 4, 2025After the close+5.5%
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha's call on XRNStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in

Analyst Ratings & Price Targets

Analyst Ratings →
AI Starter and AI Pro
Full analyst coverage on XRN
  • Every upgrade, downgrade and initiation as it happens
  • Every price target change, raised or cut
  • Consensus rating with the average, high and low targets
  • Each firm's full rating history on XRN

Technical Analysis

XRN · as of the Nov 20 close · updated each morning
Downtrend, oversold

The stock is 11% below its 20 day and 24% below its 50 day average. It is 36% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 29), oversold. The nearest support is the Pivot S1 at $25.24, and the nearest resistance the Pivot at $25.70.

Short trendBearish
Long trendBearish
MomentumWeak
StretchOversold
VolatilityHigh, 4.1%/day
Key levels
$38.6552 week high+51.7%
$34.74200 day average+36.4%
$34.11100 day average+33.9%
$31.4950 day average+23.6%
$30.27Swing high (Oct 23)+18.8%
$28.1520 day average+10.5%
$25.93Pivot R1+1.8%
$25.70Pivot+0.9%
$25.47Last close
$25.24Pivot S1−0.9%
$25.1352 week low−1.3%
Indicators
RSI (14)28.90Oversold below 30Oversold
MACD-1.66Below its signal lineBearish
Stochastic9.1Near the bottom of its rangeOversold
ADX (14)48.8Strong downtrend
Williams %R-94.9Oversold below −80, overbought above −20Oversold
CCI (20)-94.7Oversold below −100, overbought above 100Neutral
Rate of change−11.3%Change over 10 sessionsBearish
ATR (14)$1.03Typical daily range, 4.0% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for XRN

What happened before

See how XRN did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.

Whale Options Flow

90D
Whale options flow for XRNHow many large options trades hit XRN, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in

See today’s whale options flow across the market →

XRN Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Strongly bullish
Strongly bearishNeutralStrongly bullish
  • ▲91 buying vs 71 selling
  • ▲Held by funds +2.5 pts
  • ▲Funds holding +4
  • ▲Superinvestors: 2 added, 1 cut
  • ●Put/call not meaningful
Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding174170+2.4%
In funds' top 1000–
Held by funds77.7%75.2%+2.5 pts
New / increased23 / 6831 / 62−2.2%
Reduced / sold out55 / 1645 / 22+6.0%
Put/call ratio–––
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See XRN institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

XRN Insider Trading

All filings →
Insider trading · 12 months
Insiders are net buyers
Bought$3.5M17 buys · 12 insiders
Sold$00 sales · 0 insiders
Cluster buy: 4 insiders bought $2.6M between Aug 10 and Aug 17.
2025-12 bought $325K2026-05 bought $625K2026-08 bought $2.6MDecMarJunSep
BoughtSoldlast 12 months
Trade dateInsiderTypeSharesPriceValue
Aug 17Matthew Fitzsimmons WhitlockChief Investment OfficerBuy1,000$36.80$37K
Aug 12Aaron Robert RosethCOOBuy13,500$36.73$496K
Aug 11Charles FitzgeraldDirectorBuy14,000$35.78$501K
Aug 11Mark Okey Decker JrCEO and PresidentBuy550$36.00$20K
Aug 11Mark Okey Decker JrCEO and PresidentBuy6,875$35.92$247K
Aug 10Charles FitzgeraldDirectorBuy27,600$35.94$992K
Every insider buy and sale for XRN over 2 years, with a link to each SEC filing. AI Pro members can get an alert the moment an insider trades.See XRN insider trades →

From SEC Form 4 filings by XRN's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.

AI Auto Pilots

Paper trading

StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether XRN is in one of them and how their past XRN trades turned out.

XRN in the AI portfolios
Loading…

XRN News Tone and Price

Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered XRN in an article yet. Here's the latest on the wider market.

XRN in the news

About Chiron Real Estate

Chiron Real Estate is a real estate investment trust based in Bethesda, Maryland. It owns healthcare properties and leases them to physician groups and regional and national healthcare systems. Its portfolio is mostly medical office buildings, along with inpatient rehabilitation facilities, surgical hospitals and other care sites, many located away from central hospital campuses. Most of its facilities are leased to a single tenant.

Headquarters
Bethesda, MD